Android app Apple app link

Arcturus Therapeutics Holdings Inc. (ARCT) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$6.8
Day's range
$7.4

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/24/2026 BTIG Thomas Shrader $20.00 $13.30   50.38%
03/04/2026 Piper Sandler Yasmeen Rahimi $25.00 $7.42   236.93%
08/22/2025 Leerink Partners Lili Nsongo $54.00 $18.51   191.73%
05/28/2025 Scotiabank Greg Harrison $32.00 $11.82   170.73%
03/10/2025 BTIG Thomas Shrader $48.00 $14.55   229.9%
11/11/2024 Canaccord Genuity Whitney Ijem $74.00 $3.02   2350.33%
08/06/2024 Canaccord Genuity Whitney Ijem $72.00 $3.20   2150%
07/02/2024 H.C. Wainwright Ed Arce $60.00 $3.38   1675.15%
05/31/2024 Piper Sandler Yasmeen Rahimi $140.00 $5.64   2382.27%
05/10/2024 Canaccord Genuity Whitney Ijem $86.00 $3.83   2145.43%
03/19/2024 Laidlaw Yale Jen $79.00 $4.83   1535.61%
11/02/2022 Barclays Gena Wang $25.00 $21.69   15.26%
11/08/2021 Goldman Sachs Madhu Kumar $30.00 $36.23   -17.2%

Arcturus Therapeutics Holdings Inc FAQ's

Arcturus Therapeutics Holdings Inc has been rated by research analysts at BTIG, Roth Capital, Piper Sandler, Leerink Partners, Scotiabank, Canaccord Genuity in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.